Richard James’ Post

View profile for Richard James

Phage-UK co-founder; Professor at Developing Novel Antibiotics Consultancy

In a search of the available literature the authors identified 37 patients with PJIs receiving adjunctive Phage Therapy. A random-effects proportional meta-analysis suggested infection remission in 78% of patients (95% CI: 39%, 95%) (I2 = 55%, p = 0.08) and 83% with a minimum 12-month follow-up (95% CI: 53%, 95%) (I2 = 26%, p = 0.26). Conclusions: Our study provides a preliminary estimate of PT’s efficacy in PJIs and informs future comparative studies. Stephanie Lesage https://lnkd.in/eMDRwHZP

Farzaneh khodaei

Senior Microbiologist ǁ Clinical and Molecular Microbiologist ǁ Phage Researcher ǁ Antimicrobial Resistance (AMR)

10mo

Thanks for sharing

Like
Reply

To view or add a comment, sign in

Explore topics